About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 5598 record(s)
Req # A-2023-00098
Visitor Log – FINTRAC CEO between October 2020 and February 2024Organization: Financial Transactions and Reports Analysis Centre of Canada
April 2024
Req # A-2023-00117
FINTRAC reports examining involvement of the legal profession with money laundering and white-collar crimeOrganization: Financial Transactions and Reports Analysis Centre of Canada
April 2024
Req # EA2024_0065724
Provide the work description in both official languages for the President and CEO of the Halifax Port Authority in addition to all records of business value concerning how the position's linguistic profile was identified.Organization: Halifax Port Authority
April 2024
Req # N/A - Request received via delivery
Please provide all records relating to the procurement of Public Affairs, Government Relations, and Communications services for the period from January 1, 2023 to the current date. This will include the name of the individuals or companies from whom services were procured, the amount of the contract for services and copies of any related contracts and invoices. Additionally, please confirm whether contracts were sole-sourced from a standing offer list or subject to a competitive process. If a competitive process was utilized, please confirm what process was used, the date of the contract award and the number of respondents for each procurement.Organization: Halifax Port Authority
April 2024
Req # A-2023-00068
Policy interpretations related to large virtual currency transaction reportingOrganization: Financial Transactions and Reports Analysis Centre of Canada
March 2024
Req # A-2023-00072
Various 2022 and 2023 statistics on money services businesses; relating to the amount of businesses registered, number of employees, policy interpretations requested, volume of transactions, and deficiencies found in compliance examinationsOrganization: Financial Transactions and Reports Analysis Centre of Canada
March 2024
Req # A-2023-00089
Questions, answers and interpretations concerning politically exposed personsOrganization: Financial Transactions and Reports Analysis Centre of Canada
March 2024
Req # A-2016-000420
Documents relating to Health Canada’s approval of INFLECTRA (Drug Identification Number (DIN) # 02419475): All Health Canada reviewers reports and reviewer comments; and all minutes from any pre-Supplement to a New Drug Submission (SNDS) meetings between Celltrion (health care company) and Health Canada between September 1, 2014 and June 30, 2015.Organization: Health Canada
March 2024
Req # A-2019-001464
All domestic Adverse Drug Reaction (ADR) reports for Tetanus, Diphtheria and Pertussis (Tdap) Hepatitis B, Measles, Mumps and Rubella (MMR), Varicelli, Inactivated Polio Vaccine (IPV), Diphtheria, Tetanus and Pertussis (DTaP), Flu for the period of October 1, 2018 - end of March 2019.Organization: Health Canada
March 2024
Req # A-2019-001525
The Clinical Overview, Clinical Summary of Efficacy and Clinical Summary of Safety submitted to Health Canada as part of the Supplemental New Drug Submission (SNDS) (control number: 204690; decision date: 2018-03-29) in respect of TALTZ.Organization: Health Canada
March 2024